Related Experiment Video
Updated: Jun 12, 2025

Isolation and Functional Analysis of Mitochondria from Cultured Cells and Mouse Tissue
Published on: March 23, 2015
Harnessing Nur77's mitochondrial apoptotic pathway: A promising therapeutic strategy for targeted disease
Ruihai Fu1, Dandan Ling2, Qiqi Zhang3
1School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong Province, PR China.
Abstract:
The role of mitochondria in disease development cannot be overlooked, and the targeting of mitochondria for the treatment of disease has emerged as a significant area of research in recent years. Mitochondria are the control center of the intrinsic apoptotic pathway, and their normal functions are finely regulated by a series of complex mechanisms. The nuclear receptor Nur77 is closely related to the functions of the mitochondria and is an active pro-apoptotic member of the nuclear receptor superfamily. The translocation of Nur77 to the mitochondria can promote the conversion of the anti-apoptotic protein Bcl-2 to a pro-apoptotic state, disrupt the balance between mitochondrial fission and fusion, and inhibit mitophagy. These effects lead to irreversible damage to mitochondria and apoptosis, ultimately accelerating the progression of the disease. Here, we review the mechanism and targeted drug development of the mitochondrial apoptosis pathway activated by Nur77 in human diseases, helping to understand the new advances in disease treatment.
Insights
Mitochondria play a key role in disease. Targeting the nuclear receptor Nur77
Area of Science:
- Mitochondrial biology and disease pathogenesis.
Background:
- Mitochondria are central to apoptosis and cellular homeostasis.
- Dysregulation of mitochondrial function contributes to various diseases.
- The nuclear receptor Nur77 is implicated in mitochondrial regulation.
Purpose of the Study:
- To review the mechanisms by which Nur77 influences mitochondrial apoptosis.
- To explore targeted drug development strategies for Nur77-mediated mitochondrial pathways in diseases.
Main Methods:
- Review of existing literature on Nur77, mitochondria, and apoptosis.
- Analysis of molecular mechanisms linking Nur77 to mitochondrial dysfunction.
- Examination of therapeutic strategies targeting Nur77 and mitochondrial pathways.
Main Results:
- Nur77 translocation to mitochondria promotes apoptosis by altering Bcl-2 balance, disrupting mitochondrial dynamics, and inhibiting mitophagy.
- These mitochondrial disruptions lead to cellular damage and disease progression.
- Targeting Nur77 offers a potential therapeutic avenue for diseases involving mitochondrial dysfunction.
Conclusions:
- Nur77 is a critical mediator of mitochondrial apoptosis and disease progression.
- Targeting Nur77-activated mitochondrial pathways represents a promising strategy for novel disease treatments.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
06:05An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Intrinsic Apoptotic Pathway
Apoptosis
The Extrinsic Apoptotic Pathway
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Membranes